Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
143.08
+4.29 (3.09%)
At close: May 12, 2025, 4:00 PM
143.08
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
CRL Analyst Ratings
Total Analysts
15
Consensus Rating
Hold
Price Target
$184.00
Upside
+28.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $145 → $155 | Hold | Maintains | $145 → $155 | +8.33% | May 8, 2025 |
| Baird | Baird | Hold Maintains $118 → $140 | Hold | Maintains | $118 → $140 | -2.15% | May 8, 2025 |
| Barclays | Barclays | Hold Maintains $160 → $145 | Hold | Maintains | $160 → $145 | +1.34% | Apr 10, 2025 |
| Mizuho | Mizuho | Hold Maintains $175 → $155 | Hold | Maintains | $175 → $155 | +8.33% | Apr 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $190 → $170 | Strong Buy → Hold | Downgrades | $190 → $170 | +18.81% | Mar 21, 2025 |
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $155 → $175 | Strong Sell → Hold | Upgrades | $155 → $175 | +22.31% | Mar 4, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $175 → $165 | Hold | Maintains | $175 → $165 | +15.32% | Feb 20, 2025 |
| Baird | Baird | Hold Maintains $177 → $173 | Hold | Maintains | $177 → $173 | +20.91% | Feb 20, 2025 |
| Barclays | Barclays | Hold Maintains $166 → $160 | Hold | Maintains | $166 → $160 | +11.83% | Feb 20, 2025 |
| Barclays | Barclays | Hold Maintains $205 → $166 | Hold | Maintains | $205 → $166 | +16.02% | Feb 18, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $220 → $184 | Hold | Maintains | $220 → $184 | +28.60% | Feb 5, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $215 → $175 | Hold | Maintains | $215 → $175 | +22.31% | Feb 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $220 → $190 | Strong Buy | Maintains | $220 → $190 | +32.79% | Jan 23, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 22, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $250 → $185 | Strong Buy → Hold | Downgrades | $250 → $185 | +29.30% | Jan 17, 2025 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jan 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.